Hao CF - Search Results

1

[Effects of exogenous ER beta expression on the cell growth properties of MCF-7 breast cancer cell line].

Zhu JH, Ye QN, Song ST, Jiang ZF, Yan JH, Hao CF, Huang CF. Zhu JH, et al. Among authors: hao cf. Zhonghua Zhong Liu Za Zhi. 2006 Feb;28(2):103-6. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16750012 Chinese.

2

[Relation of dose intensity and efficacy, toxicity in paclitaxel as a single agent for advanced breast cancer].

Liu F, Jiang ZF, Song ST, Liu XQ, Wang T, Yan M, Zhang SH, Hao CF, Sun JZ, Shen G. Liu F, et al. Among authors: hao cf. Zhonghua Zhong Liu Za Zhi. 2005 Jan;27(1):56-8. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 15771802 Chinese.

3

Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.

Zhang H, Xie X, Zhu X, Zhu J, Hao C, Lu Q, Ding L, Liu Y, Zhou L, Liu Y, Huang C, Wen C, Ye Q. Zhang H, et al. J Biol Chem. 2005 Dec 30;280(52):43188-97. doi: 10.1074/jbc.M506598200. Epub 2005 Oct 11. J Biol Chem. 2005. PMID: 16219765 Free article.

4

CSCO expert consensus on the diagnosis and treatment of breast cancer brain metastasis.

Wang T, Chen J, Yang J, Fu M, Hua W, Jia W, Liu Y, Wang B, Yan M, Zhou J, Hao C, Chen J, Ou D, Jiang T, Mao Y, Jiang Z; CSCO expert panel of breast cancer*; CSCO expert panel of breast cancer. Wang T, et al. Transl Breast Cancer Res. 2022 Jul 30;3:22. doi: 10.21037/tbcr-22-30. eCollection 2022. Transl Breast Cancer Res. 2022. PMID: 38751521 Free PMC article. Review.

5

Chinese Society of Clinical Oncology (CSCO) Breast Cancer Guidelines 2022.

Jiang Z, Li J, Chen J, Liu Y, Wang K, Nie J, Wang X, Hao C, Yin Y, Wang S, Yan M, Wang T, Yan Y, Chen X, Song E; CSCO BC guideline working group. Jiang Z, et al. Transl Breast Cancer Res. 2022 Apr 30;3:13. doi: 10.21037/tbcr-22-21. eCollection 2022. Transl Breast Cancer Res. 2022. PMID: 38751537 Free PMC article. Review.

6

Expert consensus on the clinical application of immunotherapy in breast cancer: 2024.

Wang K, Yang J, Wang B, Liu Q, Wang X, Yin Y, Wang H, Wang S, Hao C, Hao X, Liu Y, Jiang Z; Chinese Society of Clinical Oncology Breast Cancer Committee*; Chinese Society of Clinical Oncology Breast Cancer Committee. Wang K, et al. Transl Breast Cancer Res. 2024 Apr 29;5:9. doi: 10.21037/tbcr-24-15. eCollection 2024. Transl Breast Cancer Res. 2024. PMID: 38751677 Free PMC article. Review.

7

Chinese Society of Clinical Oncology (CSCO) Breast Cancer guidelines 2024.

Li J, Hao C, Wang K, Zhang J, Chen J, Liu Y, Nie J, Yan M, Liu Q, Geng C, Wang X, Wang H, Wang S, Wu J, Yin Y, Song E, Jiang Z. Li J, et al. Transl Breast Cancer Res. 2024 Jul 25;5:18. doi: 10.21037/tbcr-24-31. eCollection 2024. Transl Breast Cancer Res. 2024. PMID: 39184927 Free PMC article. Review.

8

[Docetaxel and capecitabine combination chemotherapy for patients with anthracycline-resistant metastatic breast cancer].

Li SF, Wang X, Wang C, He LH, Shi YH, Hao CF, Dong GL, Tong ZS. Li SF, et al. Among authors: hao cf. Zhonghua Zhong Liu Za Zhi. 2008 Dec;30(12):944-6. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19174000 Chinese.

9

Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer.

Jia Y, Song Y, Dong G, Hao C, Zhao W, Li S, Tong Z. Jia Y, et al. Sci Rep. 2019 Sep 10;9(1):12939. doi: 10.1038/s41598-019-49373-w. Sci Rep. 2019. PMID: 31506496 Free PMC article.

10

The effects of RKIP gene expression on the biological characteristics of human triple-negative breast cancer cells in vitro.

Hao C, Wei S, Tong Z, Li S, Shi Y, Wang X, Zhu ZH. Hao C, et al. Tumour Biol. 2012 Aug;33(4):1159-67. doi: 10.1007/s13277-012-0358-7. Epub 2012 Feb 29. Tumour Biol. 2012. PMID: 22373584

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters